Insider Trading & Ownership of Michelle Robertson

Location
Foster City, CA
Summary
The estimated net worth of Michelle Robertson is at least $1,813,746 dollars as of 19 Feb 2026. Michelle Robertson is the EVP, CHIEF FINANCIAL OFFICER of Editas Medicine, Inc. and owns shares of Editas Medicine, Inc. (EDIT) stock worth about $1.16M. Michelle Robertson is the EVP, CHIEF FINANCIAL OFFICER of GERON CORP and owns shares of GERON CORP (GERN) stock worth about $535.5K. Michelle Robertson is the Director of Verastem, Inc. and owns shares of Verastem, Inc. (VSTM) stock worth about $116.5K.
Signature
/s/ Michelle Robertson
All Insider Reports
All Insider Reports

Follow Filing Activity

Follow Michelle Robertson and return when a new Insider Trading filing changes the record on this page.

This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.

Key facts

  • Michelle Robertson has 3 issuer positions tracked on this page.
  • Estimated disclosed ownership value: $1,813,746.
  • Recent insider filing activity is available below.

Change

  • Largest disclosed position: Editas Medicine, Inc. ($1,161,750).
  • Past-year value change for that position: .

Research use

  • This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
  • You can cross-check role, issuer, and filing chronology directly against the SEC source.

Evidence

Filed on Form 4

Insider ownership context is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Ownership of Michelle Robertson

VSTM Forms 3/4/5

Verastem, Inc.

Relationship
Director
Holdings value
$116,495
Past year net change
Change %
Report period
22 May 2025

Insider Transactions Reported by Michelle Robertson:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .